Table 2.
Cases |
Controls |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SNP | R/NR | 11 | 12 | 22 | 1 | 11 | 12 | 22 | 1 | HWE P | P (trend) | OR (95% CI) | Adjusted OR (95% CI)a |
Taiwan aborigines | |||||||||||||
rs9994944 | G/A | 229 | 221 | 61 | 0.66 | 324 | 392 | 124 | 0.62 | 0.76 | 1.87 × 10−2 | 1.21 (1.03–1.43) | 1.26(1.05–1.52) |
rs2074388 G565D | A/G | 180 | 243 | 88 | 0.59 | 214 | 414 | 212 | 0.50 | 0.68 | 9.03 × 10−6 | 1.43 (1.22–1.67) | 1.41(1.18–1.69) |
rs13148353 H642R | G/A | 191 | 240 | 80 | 0.61 | 244 | 404 | 192 | 0.53 | 0.32 | 1.04 × 10−5 | 1.36 (1.17–1.59) | 1.39(1.16–1.66) |
rs2074379 M732I | A/G | 184 | 246 | 81 | 0.60 | 237 | 405 | 198 | 0.52 | 0.33 | 1.03 × 10−4 | 1.36 (1.17–1.59) | 1.37(1.14–1.63) |
rs11726117 M861T | C/T | 198 | 237 | 76 | 0.62 | 244 | 396 | 200 | 0.53 | 0.11 | 3.78 × 10−6 | 1.44 (1.23–1.69) | 1.45(1.21–1.73) |
rs231247 R1084R | G/A | 195 | 233 | 83 | 0.61 | 225 | 414 | 201 | 0.51 | 0.70 | 2.00 × 10−6 | 1.46 (1.25–1.71) | 1.48(1.24–1.77) |
rs55840220 T1145T | A/G | 23 | 131 | 357 | 0.17 | 21 | 125 | 694 | 0.10 | <0.01 | 1.89 × 10−7 | 1.76 (1.42–2.18) | 1.71 (1.33–2.18) |
rs231253, 3' UTR | G/C | 190 | 239 | 82 | 0.61 | 223 | 416 | 201 | 0.51 | 0.80 | 3.48 × 10−6 | 1.45 (1.24–1.70) | 1.43(1.20–1.71) |
rs960583, 3' UTR | A/G | 25 | 159 | 327 | 0.20 | 19 | 224 | 597 | 0.16 | 0.71 | 1.37 × 10−3 | 1.39 (1.13–1.69) | 1.33(1.06–1.66) |
Taiwanese Han | |||||||||||||
rs11726117 M861T | C/T | 70 | 31 | 3 | 0.82 | 209 | 168 | 30 | 0.72 | 0.64 | 2.50 × 10−3 | 1.82 (1.23–2.70) | 2.41 (1.41–4.12) |
rs231247 R1084R | G/A | 70 | 28 | 6 | 0.81 | 204 | 167 | 36 | 0.71 | 0.83 | 4.08 × 10−3 | 1.72 (1.18–2.50) | 2.15 (1.31–3.50) |
rs231253, 3' UTR | G/C | 63 | 35 | 6 | 0.77 | 215 | 164 | 28 | 0.73 | 0.66 | 1.92 × 10−1 | 1.27 (0.89–1.83) | 1.36 (0.84–2.20) |
Pooled analysisb | |||||||||||||
rs11726117 M861T | C/T | 268 | 268 | 79 | 0.65 | 453 | 564 | 230 | 0.59 | 2.89 × 10−8 | 1.51 (1.31–1.75) | 1.53 (1.30–1.81) | |
rs231247 R1084R | G/A | 265 | 261 | 89 | 0.64 | 429 | 581 | 237 | 0.58 | 2.05 × 10−8 | 1.52 (1.31–1.75) | 1.55 (1.31–1.83) | |
rs231253, 3' UTR | G/C | 253 | 274 | 88 | 0.63 | 438 | 580 | 229 | 0.58 | 1.53 × 10−6 | 1.42 (1.23–1.65) | 1.42 (1.21–1.68) |
R, risk allele; NR, non-risk allele; 11 indicates at-risk homozygote, 12 indicates heterozygote; 22 indicates wild-type homozygote; HWE, Hardy-Weinberg equilibrium; 3' UTR, three prime untranslated region; OR, odd ratios; CI, confidence interval.
ORs and P-values were for each case-control study separately under an additive model of inheritance.
aOR with 95% CI in parentheses was adjusted for age, gender, body mass index, hypertension, alcohol use, total cholesterol, log (triglycerides), creatinine and hyperuricaemia by a logistic regression model.
bPooled analysis was performed by the Cochran-Mantel-Haenszel test method using the PLINK v1.07. Three SNPs revealed homogeneity in the association with gout (Breslow-Day test, P > 0.33). OR with 95% CI in parentheses was adjusted for ethnicity, hyperuricaemia and other covariates using a logistic regression model.